Published in
South African Medical Association, South African Medical Journal, 2(106), p. 139
DOI: 10.7196/samj.2016.v106i2.10534
Links
- ORCID
- South African Medical Association | PDF
- [samj.org.za] | PDF
- [repository.up.ac.za] | PDF
- [www.researchgate.net] | PDF
- [samj.org.za] | PDF
Tools
Implications of direct-to-consumer whole-exome sequencing in South Africa
Journal article published in 2016 by
Zané Lombard 
,
Jantina de Vries,
Fiona Baine,
Amanda Krause,
Anneline Lochan,
Shelley Macualay,
Careni Spencer,
Colleen Aldous,
Karen Fieggen,
Bertram Henderson,
Eileen Hoal,
Craig Kinnear,
Noelene Kinsley,
Alison September,
Michael Urban
and other authors.
,
Jantina de Vries,
Fiona Baine,
Amanda Krause,
Anneline Lochan,
Shelley Macualay,
Careni Spencer,
Colleen Aldous,
Karen Fieggen,
Bertram Henderson,
Eileen Hoal,
Craig Kinnear,
Noelene Kinsley,
Alison September,
Michael Urban
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 
Abstract
This editorial examines a number of vitally important ethical, legal and scientific concerns that have to be addressed to ensure proper and ethical implementation of direct-to-consumer whole-exome sequencing in South Africa. Individuals taking part in this endeavour must be fully informed of the positive and negative sequelae.